Spruce Biosciences, Inc.
SPRB
$60.95
$0.891.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.97M | -47.88M | -48.34M | -55.45M | -53.04M |
| Total Depreciation and Amortization | 21.00K | 25.00K | 32.00K | 37.00K | 46.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.34M | 1.59M | 2.21M | 4.43M | 5.60M |
| Change in Net Operating Assets | -724.00K | -1.28M | -5.36M | -2.74M | -8.57M |
| Cash from Operations | -33.33M | -47.55M | -51.46M | -53.73M | -55.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.06M | -1.62M | -1.62M | -1.62M | -1.62M |
| Issuance of Common Stock | 50.07M | 17.00K | 14.00K | 66.00K | 246.00K |
| Repurchase of Common Stock | -831.00K | -233.00K | -233.00K | -244.00K | -246.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.70M | 0.00 | 0.00 | -6.00K | -- |
| Cash from Financing | 43.48M | -1.84M | -1.84M | -1.81M | -1.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.15M | -49.39M | -53.30M | -55.54M | -57.59M |